Healthcare payment software provider Waystar is betting big on artificial intelligence to revolutionize revenue cycle management, and early results suggest the strategy is paying off. The company reported third-quarter 2026 revenue of $325.6 million—a 21% year-over-year increase—while simultaneously deploying more than 20 AI-driven capabilities designed to create what executives call an "autonomous revenue cycle."

The Louisville-based firm, which processes 8.5 billion healthcare payment transactions annually representing over $3 trillion in gross claims, secured its largest client win ever in Q3: a major East Coast health system with approximately $7 billion in annual net patient revenue. The deal is particularly notable because the system is replacing more than 20 separate vendors with Waystar's integrated platform, signaling a broader industry trend toward consolidation of fragmented revenue cycle operations.

AI Capabilities Deliver Measurable Efficiency Gains

Waystar's autonomous claim resubmission feature, launched during the third quarter, exemplifies the shift from manual to automated healthcare financial operations. According to the company, this single AI capability is estimated to autonomously resubmit up to $5 billion in previously rejected claims annually while eliminating more than 400,000 hours of manual work per year across its client base.

The company's acquisition of Iodine Software is exceeding expectations, with bookings surpassing year-to-date targets by 74% in Q3. Iodine's clinical documentation integrity and pre-bill anomaly detection products generated nearly $30 million in bookings through the third quarter, with a combined pipeline now exceeding $100 million. This performance validates Waystar's strategy of combining clinical intelligence with financial data and payer connectivity to create integrated automation solutions.

CEO Matt Hawkins emphasized the company's vision during the earnings call, describing a future where AI handles routine revenue cycle tasks autonomously while human staff focus on complex exceptions and strategic initiatives.

Expanding Client Base and Market Penetration

Waystar now serves 30,000 total clients representing 1.5 million distinct providers, with 1,488 clients generating more than $100,000 in trailing 12-month revenue—a 14% year-over-year increase. The company's clinical intelligence capabilities now span approximately one-third of U.S. hospital discharges, providing substantial data for training and refining AI models.

Subscription revenue reached $181 million in Q3, representing 34% growth, while provider revenue hit $243 million with 28% growth. The company has also added more than 100 direct health plan connections supporting 50 million transactions annually, enhancing interoperability across the healthcare payment ecosystem.

However, the path to revenue realization requires patience. Large platform implementations typically require 12 to 18 months for full revenue conversion, meaning Q3's major wins won't fully impact financial results until 2027 or 2028. The company's backlog of deals exceeding $100,000 in annual sales is up more than 50% year-over-year, suggesting continued momentum.

Financial Outlook and Market Position

For full-year 2026, Waystar forecasts revenue between $1.277 billion and $1.287 billion, with fourth-quarter revenue expected at approximately $323 million, representing 6% growth. CFO Alpana Wegner, who joined in August 2026, noted that the company is balancing aggressive growth investments in AI capabilities with disciplined financial management.

William Blair analyst Ryan Daniels maintains an "Outperform" rating on the company, citing the strategic value of Waystar's integrated platform approach in a market where health systems are actively seeking to reduce vendor complexity and operational costs through consolidation and automation.

Sources

  1. Waystar touts bigger health system wins and growing AI pipeline — Fierce Healthcare